Standout Papers

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially diff... 2013 2026 2017 2021 384
  1. JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes (2013)
    Elisa Rumi, Daniela Pietra et al. Blood

Immediate Impact

3 from Science/Nature 49 standout
Sub-graph 1 of 21

Citing Papers

A new era of cancer phototherapy: mechanisms and applications
2024 Standout
Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial
2023 Standout
16 intermediate papers

Works of Chiara Elena being referenced

Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: a real clinical problem?
2015
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
2013 Standout
and 7 more

Author Peers

Author Last Decade Papers Cites
Chiara Elena 1972 1602 1309 61 2.4k
Alessandro Pancrazzi 2208 1660 1464 42 2.5k
Bettina Gisslinger 1358 1062 1048 53 1.8k
Katerina Zoi 1290 1331 1451 34 2.2k
Yana Pikman 2001 1791 1488 40 2.6k
Lisa Pieri 2189 1714 1471 57 2.5k
Éric Lippert 1414 1280 953 101 2.1k
Margherita Maffioli 2489 2430 1381 61 3.1k
Domenica Caramazza 2211 1866 1286 35 2.5k
Amy V. Jones 1985 1856 1971 43 3.2k
Jan Samuelsson 1844 1870 1125 75 2.7k

All Works

Loading papers...

Rankless by CCL
2026